| Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine RP Payne, S Longet, JA Austin, DT Skelly, W Dejnirattisai, S Adele, ... Cell 184 (23), 5699-5714. e11, 2021 | 311 | 2021 |
| T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study A Angyal, S Longet, SC Moore, RP Payne, A Harding, T Tipton, ... The Lancet Microbe 3 (1), e21-e31, 2022 | 188 | 2022 |
| Dose-dependent response to infection with SARS-CoV-2 in the ferret model and evidence of protective immunity KA Ryan, KR Bewley, SA Fotheringham, GS Slack, P Brown, Y Hall, ... Nature communications 12 (1), 81, 2021 | 177 | 2021 |
| Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern DT Skelly, AC Harding, J Gilbert-Jaramillo, ML Knight, S Longet, A Brown, ... Nature communications 12 (1), 5061, 2021 | 173 | 2021 |
| Comparison of rhesus and cynomolgus macaques as an infection model for COVID-19 FJ Salguero, AD White, GS Slack, SA Fotheringham, KR Bewley, ... Nature communications 12 (1), 1260, 2021 | 142 | 2021 |
| A murine genital-challenge model is a sensitive measure of protective antibodies against human papillomavirus infection S Longet, JT Schiller, M Bobst, P Jichlinski, D Nardelli-Haefliger Journal of virology 85 (24), 13253-13259, 2011 | 113 | 2011 |
| SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease E Barnes, CS Goodyear, M Willicombe, C Gaskell, S Siebert, T I de Silva, ... Nature Medicine 29 (7), 1760-1774, 2023 | 88 | 2023 |
| Viral evasion of the complement system and its importance for vaccines and therapeutics J Mellors, T Tipton, S Longet, M Carroll Frontiers in immunology 11, 1450, 2020 | 82 | 2020 |
| Secretory IgA in complex with Lactobacillus rhamnosus potentiates mucosal dendritic cell-mediated Treg cell differentiation via TLR regulatory proteins, RALDH2 and secretion of … J Mikulic, S Longet, L Favre, J Benyacoub, B Corthesy Cellular & molecular immunology 14 (6), 546-556, 2017 | 64 | 2017 |
| Human plasma-derived polymeric IgA and IgM antibodies associate with secretory component to yield biologically active secretory-like antibodies S Longet, S Miled, M Lötscher, SM Miescher, AW Zuercher, B Corthésy Journal of Biological Chemistry 288 (6), 4085-4094, 2013 | 62 | 2013 |
| Vaccine-induced immunity provides more robust heterotypic immunity than natural infection to emerging SARS-CoV-2 variants of concern. DT Skelly, AC Harding, J Gilbert-Jaramillo, ML Knight, S Longet, A Brown, ... | 52 | 2021 |
| mRNA vaccine CVnCoV protects non-human primates from SARS-CoV-2 challenge infection S Rauch, K Gooch, Y Hall, FJ Salguero, MJ Dennis, FV Gleeson, D Harris, ... Biorxiv, 2020.12. 23.424138, 2020 | 51 | 2020 |
| Targeted strategies for mucosal vaccination S Longet, MLE Lundahl, EC Lavelle Bioconjugate Chemistry 29 (3), 613-623, 2018 | 42 | 2018 |
| Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV A Ogbe, M Pace, M Bittaye, T Tipoe, S Adele, J Alagaratnam, PK Aley, ... JCI insight 7 (7), e157031, 2022 | 40 | 2022 |
| Longitudinal antibody and T cell responses in Ebola virus disease survivors and contacts: an observational cohort study R Thom, T Tipton, T Strecker, Y Hall, JA Bore, P Maes, FR Koundouno, ... The Lancet Infectious Diseases 21 (4), 507-516, 2021 | 40 | 2021 |
| Technological approaches for improving vaccination compliance and coverage C Lemoine, A Thakur, D Krajišnik, R Guyon, S Longet, A Razim, S Górska, ... Vaccines 8 (2), 304, 2020 | 38 | 2020 |
| Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimens SC Moore, B Kronsteiner, S Longet, S Adele, AS Deeks, C Liu, ... Med 4 (3), 191-215. e9, 2023 | 37 | 2023 |
| T-cell and antibody responses to first BNT162b2 vaccine dose in previously SARS-CoV-2-infected and infection-naive UK healthcare workers: a multicentre, prospective … A Angyal, S Longet, S Moore, RP Payne, A Harding, T Tipton, P Rongkard, ... | 35 | 2020 |
| Divergent trajectories of antiviral memory after SARS-CoV-2 infection A Tomic, DT Skelly, A Ogbe, D O’Connor, M Pace, E Adland, F Alexander, ... Nature communications 13 (1), 1251, 2022 | 33 | 2022 |
| An oral alpha-galactosylceramide adjuvanted Helicobacter pylori vaccine induces protective IL-1R- and IL-17R-dependent Th1 responses S Longet, A Abautret-Daly, CJH Davitt, CP McEntee, V Aversa, M Rosa, ... npj Vaccines 4 (1), 45, 2019 | 33 | 2019 |
